This afternoon at 4:12pm PST #AACR26, Dr. Pat LoRusso presents updates on dose escalation results from a Phase 1 study of #ZW191 during a...

AACR 2026 现场信号· @ · X·2026-04-22 05:00· 2026-04-22评分60

正文 · 原文

This afternoon at 4:12pm PST #AACR26, Dr. Pat LoRusso presents updates on dose escalation results from a Phase 1 study of #ZW191 during a #clinicaltrials mini-symposium. https://t.co/sHcYw4rrQW
@SmilowCancer @AACR https://t.co/0u615wXCyr

热度 4 · 4 赞 · 0 回复 · 0 转发

会议摘要

CT306NCT06555744按代号 ZW191 对上

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results

Patricia LoRusso, David Sommerhalder, Kosei Hasegawa, Kenichi Harano, David S. Tan, Noboru Yamamoto, David M. O’Malley, Kathleen N. Moore, Sarah E. Church, Lin Lu, Sabeen Mekan, Pranshul Chauha, Jung-Yun Lee

读摘要原文 →

来源：AACR 2026 现场信号 · x.com